Remove 2025 Remove enablement Remove founder
article thumbnail

Terra Security Wins 2025 CrowdStrike and AWS Cybersecurity Accelerator for AI-Powered Pentesting

American Entrepreneurship

In a landmark event at RSA 2025, CrowdStrike and Amazon Web Services (AWS) revealed Terra Security as the winner of the highly competitive 2025 Cybersecurity Startup Accelerator. CrowdStrike and AWS Expand AI Innovation Through Cybersecurity Accelerator The 2025 program attracted hundreds of applicants from the U.S.,

article thumbnail

The VC Stack Makeover: What Today's Funds Need - Webinar

The Seraf Compass

You’re juggling pipeline, diligence, founder support, LP management, and usually doing it all with a lean team. Founders share materials via DocSend, and the cap table gets vetted in Carta or Capboard Docs & Close : Final agreements and SAFEs are dropped into structured folders. Good tools don’t replace instinct. They sharpen it.

VC
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Creator Ventures Raises $45M Fund II to Back the Next Generation of Consumer Internet Startups

American Entrepreneurship

Creator Ventures, founded in 2022 by cousins Sasha Kaletsky and Caspar Lee , is uniquely positioned to invest in the next wave of AI-enabled consumer applications, marketplaces, creative tools, and SaaS platforms reshaping the digital landscape. As a creator, Ive lived through the digital evolution firsthand, said Lee. Thats what we bring.

article thumbnail

Qolab’s Funding from Applied Ventures Advances Quantum Computing Manufacturing

American Entrepreneurship

These efforts will be showcased at the upcoming American Physical Society (APS) March Meeting on March 17, 2025, where Dr. John Martinis, CTO and Co-founder of Qolab, will present the latest results from this partnership. Martinis is a renowned physicist and one of the worlds foremost experts in superconducting qubits.

article thumbnail

Revolution Growth’s Latest Investment in Healthcare and AI: Pathos, the Company Re-Engineering the…

Revolution

Meet Pathos  — the clinical-stage, AI-enabled biotech company that is re-engineering the drug development process to bring novel drugs to market. The Results To-Date: In the last 12 months, Pathos has acquired two clinical-stage precision oncology assets with plans to launch their Phase II clinical trials in 2025.

article thumbnail

EnCharge AI Raises $100M for Development of First-of-its-kind Analog In-memory-computing AI Chips

American Entrepreneurship

As Dan Ateya, President and Managing Director of RTX Ventures, stated, EnCharges technology is poised to enable advancements in environments previously inaccessible due to the limitations of conventional processors.

article thumbnail

QuSecure Names Rebecca Krauthamer as CEO, Gains Series A Funding

American Entrepreneurship

The capital infusion enables QuSecure to enhance its product offerings, expand its customer base, and drive the adoption of its pioneering QuProtect platform, designed to future-proof enterprise cybersecurity against the threats posed by quantum computing. It is expected to grow exponentially.